If you're one of the 33 million Americans enrolled in a Medicare Advantage plan in 2026, a quiet but consequential fight is playing out in Washington that could directly affect whether your doctor's recommended treatment gets approved — or gets blocked by a computer. House and Senate Democrats have moved to overturn a Centers for Medicare and Medicaid Services pilot program called WISeR, short for Widely Integrated Systematic Evidence Review, which would allow Medicare Advantage insurers to use artificial intelligence algorithms to make prior authorization decisions. The push to block this program reflects growing alarm among patient advocates, physicians, and now lawmakers that AI-driven prior auth could turbocharge a system that already denies or delays care at troubling rates.
Prior authorization is the process your Medicare Advantage plan uses to decide whether it will cover a specific drug, procedure, specialist visit, or medical device before you receive it. Unlike Original Medicare — Parts A and B — which generally pays for any medically necessary service a doctor orders, Medicare Advantage plans are run by private insurers like UnitedHealthcare, Humana, Aetna, and CVS Health, and those insurers have broad authority to require prior authorization as a cost-control tool. According to a 2024 report from the HHS Office of Inspector General, Medicare Advantage plans denied about 6% of prior authorization requests in a single year — and a significant portion of those denials were later overturned on appeal, suggesting they were medically inappropriate in the first place. The concern with WISeR is that replacing human clinical reviewers with AI could make this process faster but not necessarily fairer.
The WISeR pilot was developed by CMS as a way to standardize and potentially speed up prior authorization decisions across Medicare Advantage plans. Proponents argue that AI can reduce inconsistency in how insurers apply clinical criteria, potentially cutting down on arbitrary denials. But critics — including the physicians' groups, patient advocacy organizations, and now Democratic members of Congress — argue that the real-world effect would be the opposite. An AI system trained on claims data and cost patterns may systematically flag certain treatments as unnecessary based on population-level statistics, even when an individual patient's clinical situation clearly warrants the care. The American Medical Association has been particularly vocal, noting that prior authorization already forces physicians to spend an average of 14 hours per week on administrative tasks, and that AI-driven systems could add another layer of opaque, algorithm-based barriers between patients and their doctors.
For Medicare Advantage enrollees, the practical stakes are immediate and personal. Imagine your cardiologist recommends a cardiac catheterization, or your oncologist wants to start you on a specific chemotherapy regimen. Under current rules, your insurer may require prior authorization before approving that care. A human clinical reviewer — ideally a physician in the relevant specialty — is supposed to evaluate whether the request meets the plan's coverage criteria. Under an AI-driven system like WISeR, that initial decision could be made by an algorithm in seconds, with no physician involved at the first stage. If the AI denies the request, you and your doctor would then need to navigate an appeals process that can take days or weeks — time that patients with serious conditions often don't have. The OIG has documented cases where prior authorization delays led to patients being discharged from hospitals prematurely or missing critical treatment windows.
The Congressional effort to overturn WISeR is being pursued through the Congressional Review Act, a legislative tool that allows Congress to nullify federal agency rules and pilot programs within a specific window. Democrats in both chambers have argued that CMS did not adequately consult with patient advocates or clinicians before launching the pilot, and that the program lacks sufficient safeguards to ensure AI decisions are reviewed by qualified medical professionals before they affect patient care. It's worth noting that this is not a partisan issue in the way many health policy fights are — some Republican lawmakers have also expressed concern about AI in prior authorization, and bipartisan legislation like the Improving Seniors' Timely Access to Care Act, which passed the House overwhelmingly in a prior Congress, has sought to reform prior authorization broadly. The specific fight over WISeR, however, is currently being led by Democrats.
If you're enrolled in a Medicare Advantage plan right now, there are concrete steps you can take to protect yourself regardless of how the WISeR fight resolves. First, know your plan's prior authorization requirements before you need care — your plan's Evidence of Coverage document, which you should have received during your last Annual Enrollment Period (October 15 through December 7), lists which services require prior auth. Second, if your doctor recommends a treatment that requires prior authorization, ask your doctor's office to submit the request with detailed clinical documentation. Vague or incomplete requests are more likely to be denied, whether by a human or an algorithm. Third, if a prior authorization request is denied, you have the right to appeal. For Medicare Advantage, the standard appeal timeline requires a decision within 30 days for non-urgent requests and 72 hours for urgent ones. You can also request an expedited appeal if your health is at risk.
Beyond the appeals process, you have additional tools. Your doctor can request a peer-to-peer review, which means they speak directly with the insurer's medical reviewer to make the clinical case for your treatment. This step alone reverses a significant percentage of initial denials. You can also file a complaint with your State Health Insurance Assistance Program, known as SHIP, which provides free counseling to Medicare beneficiaries. SHIP counselors can help you navigate the appeals process, understand your rights, and escalate complaints to CMS if necessary. To find your local SHIP office, visit shiphelp.org or call 1-800-MEDICARE.
Looking at the bigger picture, the WISeR controversy is part of a broader reckoning over how Medicare Advantage plans use prior authorization. CMS finalized rules in 2024 requiring Medicare Advantage plans to make prior authorization decisions faster, use clinical criteria based on evidence rather than cost alone, and provide clearer explanations when denying requests. Those rules took effect in 2026 and represent real progress. But the introduction of AI into the decision-making chain raises new questions that those rules didn't fully anticipate. The core issue is accountability: when an AI denies your claim, who is responsible? What clinical criteria did the algorithm apply? Can your doctor challenge the logic of the decision, or only the outcome?
For beneficiaries comparing Medicare Advantage plans during the next Annual Enrollment Period — which runs October 15 through December 7 each year — prior authorization policies should be a key factor in your decision. Plans are required to post their prior authorization requirements on their websites, and Medicare's Plan Finder tool at medicare.gov/plan-compare allows you to compare plans side by side. Look specifically at whether a plan requires prior authorization for the types of care you use most — specialist visits, imaging, durable medical equipment, or specialty drugs. A plan with a $0 premium but aggressive prior authorization requirements may end up costing you far more in delayed or denied care than a plan with a modest monthly premium and more permissive coverage policies. The WISeR debate is a reminder that in Medicare Advantage, the fine print about how coverage decisions get made can matter just as much as the premium you pay.